Journal Article Review Ahead of print 23 citations
PubMed: 38062923 DOI: 10.1111/cts.13695
Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine.
Clin Transl Sci
Authors: Luming Wang, Danping Hu, Jinming Xu, Jian Hu, Yifei Wang
Affiliations
- Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province, Hangzhou, China.
- HANGZHOU CHEXMED TECHNOLOGY CO. LTD, Hangzhou, China.
- Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province, Hangzhou, China.
Abstract
In vitro and in vivo models play integral roles in preclinical drug research, evaluation, and precision medicine. In vitro models primarily involve research platforms based on cultured cells, typically in the form of two-dimensional (2D) cell models. However, notable disparities exist between 2D cultured cells and in vivo cells across various aspects, rendering the former inadequate for replicating the physiologically relevant functions of human or animal organs and tissues. Consequently, these models failed to accurately reflect real-life scenarios post-drug administration. Complex in vitro models (CIVMs) refer to in vitro models that integrate a multicellular environment and a three-dimensional (3D) structure using bio-polymer or tissue-derived matrices. These models seek to reconstruct the organ- or tissue-specific characteristics of the extracellular microenvironment. The utilization of CIVMs allows for enhanced physiological correlation of cultured cells, thereby better mimicking in vivo conditions without ethical concerns associated with animal experimentation. Consequently, CIVMs have gained prominence in disease research and drug development. This review aimed to comprehensively examine and analyze the various types, manufacturing techniques, and applications of CIVM in the domains of drug discovery, drug development, and precision medicine. The objective of this study was to provide a comprehensive understanding of the progress made in CIVMs and their potential future use in these fields.
MeSH
Environment, Cells, Cultured, Pharmaceutical Preparations, Precision Medicine, Biomedical Research, Tissues, Drug Development
Cited by
- Nanofibrous Scaffolds' Ability to Induce Mesenchymal Stem Cell Differentiation for Soft Tissue Regenerative Applications. Pharmaceuticals (Basel), 2025
- Biosimilars Targeting Pathogens: A Comprehensive Review of Their Role in Bacterial, Fungal, Parasitic, and Viral Infections. Pharmaceutics, 2025
- Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadata. Cell Rep Methods, 2025
- Synthetic Cathinones Induce Developmental Arrest, Reduce Reproductive Capacity, and Shorten Lifespan in the Model. J Xenobiot, 2025
- Exploring Mechanical Features of 3D Head and Neck Cancer Models. J Funct Biomater, 2025
- Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer's Disease. Int J Mol Sci, 2025
- Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine. Clin Transl Sci, 2023
- Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects. Curr Issues Mol Biol, 2025
- Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing. ACS Biomater Sci Eng, 2025
- Engineered Tissue Models to Decode Host-Microbiota Interactions. Adv Sci (Weinh), 2025
- A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Poisoning. Molecules, 2024
- How to Establish a Novel Liver Cell Culture System That Resembles the In Vivo Liver Microenvironment. Curr Protoc, 2025
- Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells. ACS Nano, 2025